User profiles for Elitsa Y Dimova
Elitsa Y. DimovaUniversity of Oulu Verified email at oulu.fi Cited by 1893 |
[HTML][HTML] Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?
A Görlach, EY Dimova, A Petry, A Martínez-Ruiz… - Redox biology, 2015 - Elsevier
… Author links open overlay panel Agnes Görlach a b , Elitsa Y. Dimova c , Andreas Petry a
b , Antonio Martínez-Ruiz d , Pablo Hernansanz-Agustín d e , Anabela P. Rolo f , Carlos M. …
b , Antonio Martínez-Ruiz d , Pablo Hernansanz-Agustín d e , Anabela P. Rolo f , Carlos M. …
[HTML][HTML] Hypoxia-inducible factors (HIFs) and phosphorylation: impact on stability, localization, and transactivity
T Kietzmann, D Mennerich, EY Dimova - Frontiers in cell and …, 2016 - frontiersin.org
The hypoxia-inducible factor α-subunits (HIFα) are key transcription factors in the mammalian
response to oxygen deficiency. The HIFα regulation in response to hypoxia occurs …
response to oxygen deficiency. The HIFα regulation in response to hypoxia occurs …
Hypoxia-inducible factor prolyl 4-hydroxylase-2 inhibition protects against development of atherosclerosis
L Rahtu-Korpela, J Määttä, EY Dimova… - … and Vascular Biology, 2016 - Am Heart Assoc
Objective— Small-molecule hypoxia-inducible factor prolyl 4-hydroxylase (HIF-P4H) inhibitors
are being explored in clinical studies for the treatment of anemia. HIF-P4H-2 (also known …
are being explored in clinical studies for the treatment of anemia. HIF-P4H-2 (also known …
[HTML][HTML] A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies
The NRF2 pathway is frequently activated in various cancer types, yet a comprehensive
analysis of its effects across different malignancies is currently lacking. We developed a NRF2 …
analysis of its effects across different malignancies is currently lacking. We developed a NRF2 …
[HTML][HTML] Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue
I Zagotta, EY Dimova, KM Debatin… - Frontiers in …, 2015 - frontiersin.org
Obesity is associated with an inflammatory status and linked with a number of pathophysiological
complications among them cardiovascular disease, type 2 diabetes mellitus, or the …
complications among them cardiovascular disease, type 2 diabetes mellitus, or the …
Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia
…, V Karhunen, J Kettunen, R Serpi, EY Dimova… - Science …, 2021 - science.org
Activation of the hypoxia-inducible factor (HIF) pathway reprograms energy metabolism.
Hemoglobin (Hb) is the main carrier of oxygen. Using its normal variation as a surrogate …
Hemoglobin (Hb) is the main carrier of oxygen. Using its normal variation as a surrogate …
Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver
EY Dimova, T Kietzmann - Thrombosis and haemostasis, 2008 - thieme-connect.com
Plasminogen activator inhibitor-1 (PAI-1) controls the regulation of the fibrinolytic system in
blood by inhibiting both urokinase-type and tissue-type plasminogen activators. Enhanced …
blood by inhibiting both urokinase-type and tissue-type plasminogen activators. Enhanced …
[PDF][PDF] The circadian clock protein CRY1 is a negative regulator of HIF-1α
EY Dimova, M Jakupovic, K Kubaichuk, D Mennerich… - Iscience, 2019 - cell.com
The circadian clock and the hypoxia-signaling pathway are regulated by an integrated
interplay of positive and negative feedback limbs that incorporate energy homeostasis and …
interplay of positive and negative feedback limbs that incorporate energy homeostasis and …
[HTML][HTML] FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol
GK Ganjam, EY Dimova, TG Unterman… - Journal of biological …, 2009 - ASBMB
Resveratrol, a polyphenol derived from grapes, exerts important effects on glucose and lipid
metabolism, yet detailed mechanisms mediating these effects remain unknown. The liver …
metabolism, yet detailed mechanisms mediating these effects remain unknown. The liver …
Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression
EY Dimova, A Samoylenko… - Antioxidants and Redox …, 2004 - liebertpub.com
Plasminogen activator inhibitor-1 (PAI-1) is the major physiological inhibitor of urokinase-type
and tissue-type plasminogen activators. It has gained special interest among clinicians …
and tissue-type plasminogen activators. It has gained special interest among clinicians …